These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 19009270

  • 1. Screening of small-molecule compounds as inhibitors of HCV entry.
    Yang JP, Zhou D, Wong-Staal F.
    Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270
    [Abstract] [Full Text] [Related]

  • 2. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
    Bartosch B, Cosset FL.
    Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
    Gentzsch J, Hinkelmann B, Kaderali L, Irschik H, Jansen R, Sasse F, Frank R, Pietschmann T.
    Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
    [Abstract] [Full Text] [Related]

  • 4. A novel small molecule inhibitor of hepatitis C virus entry.
    Baldick CJ, Wichroski MJ, Pendri A, Walsh AW, Fang J, Mazzucco CE, Pokornowski KA, Rose RE, Eggers BJ, Hsu M, Zhai W, Zhai G, Gerritz SW, Poss MA, Meanwell NA, Cockett MI, Tenney DJ.
    PLoS Pathog; 2010 Sep 02; 6(9):e1001086. PubMed ID: 20838466
    [Abstract] [Full Text] [Related]

  • 5. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, Bain C, Patel AH, Dubuisson J, Ball JK, Cosset FL.
    Hepatology; 2005 Feb 02; 41(2):265-74. PubMed ID: 15660396
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
    Mittapalli GK, Jackson A, Zhao F, Lee H, Chow S, McKelvy J, Wong-Staal F, Macdonald JE.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6852-5. PubMed ID: 21978675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
    Bürgel B, Friesland M, Koch A, Manns MP, Wedemeyer H, Weissenborn K, Schulz-Schaeffer WJ, Pietschmann T, Steinmann E, Ciesek S.
    J Viral Hepat; 2011 Aug 15; 18(8):562-70. PubMed ID: 20579278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.
    Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.
    Antiviral Res; 2010 May 15; 86(2):172-9. PubMed ID: 20156485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors.
    Ziegler S, Kronenberger B, Albrecht BA, Kaul A, Gamer AL, Klein CD, Hartmann RW.
    J Biomol Screen; 2009 Jul 15; 14(6):620-6. PubMed ID: 19531666
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.